513 drug classes · 1,794 molecules · updated daily

Drug classes by Part D spend.

Every therapeutic class represented in our 3,186-drug Part D-relevant universe, ranked by CY2024 Part D spend. Click any class to see member drugs, their cost spread, generic competition, and class-level Q&A.

Last updated
Class membership: drug master, refreshed weeklyPart D Spend: annual (CY24)NADAC: weekly

Every class, ranked by plan spend.

513 classesTotal $307.07B CY24
01
Factor Xa Inhibitor
4 molecules in class · 23 total generic manufacturers across the class
CY24 Part D spend$41.74B
→
Molecules4
Class share 13.6% of tracked Part D spend
Explorer
View class
Open →
02
GLP-1 Receptor Agonist
4 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$32.44B
→
Molecules4
Class share 10.6% of tracked Part D spend
Explorer
View class
Open →
03
Kinase Inhibitor
48 molecules in class · 68 total generic manufacturers across the class
CY24 Part D spend$26.93B
→
Molecules48
Class share 8.8% of tracked Part D spend
Explorer
View class
Open →
05
Thalidomide Analog
2 molecules in class · 23 total generic manufacturers across the class
CY24 Part D spend$13.44B
→
Molecules2
Class share 4.4% of tracked Part D spend
Explorer
View class
Open →
07
TNF Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$8.57B
→
Molecules1
Class share 2.8% of tracked Part D spend
Explorer
View class
Open →
08
Atypical Antipsychotic
18 molecules in class · 137 total generic manufacturers across the class
CY24 Part D spend$6.60B
→
Molecules18
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
09
Dipeptidyl Peptidase 4 Inhibitor
5 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$6.52B
→
Molecules5
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
10
Tumor Necrosis Factor Blocker
10 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$6.32B
→
Molecules10
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
11
Androgen Receptor Inhibitor
5 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$5.85B
→
Molecules5
Class share 1.9% of tracked Part D spend
Explorer
View class
Open →
12
Interleukin-23 Antagonist
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.78B
→
Molecules4
Class share 1.9% of tracked Part D spend
Explorer
View class
Open →
13
Insulin Analog
16 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.21B
→
Molecules16
Class share 1.7% of tracked Part D spend
Explorer
View class
Open →
14
Interleukin-12 Antagonist
6 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.16B
→
Molecules6
Class share 1.7% of tracked Part D spend
Explorer
View class
Open →
15
beta3-Adrenergic Agonist
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$5.05B
→
Molecules2
Class share 1.6% of tracked Part D spend
Explorer
View class
Open →
17
PCSK9 Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.75B
→
Molecules2
Class share 1.2% of tracked Part D spend
Explorer
View class
Open →
18
Interleukin-17A Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.63B
→
Molecules2
Class share 1.2% of tracked Part D spend
Explorer
View class
Open →
19
Guanylate Cyclase-C Agonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.26B
→
Molecules2
Class share 1.1% of tracked Part D spend
Explorer
View class
Open →
21
Janus Kinase Inhibitor
4 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$2.49B
→
Molecules4
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
22
HMG-CoA Reductase Inhibitor
6 molecules in class · 70 total generic manufacturers across the class
CY24 Part D spend$2.33B
→
Molecules6
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
23
Endothelin Receptor Antagonist
6 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$2.33B
→
Molecules6
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
25
Rifamycin Antibacterial
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$1.81B
→
Molecules2
Class share 0.6% of tracked Part D spend
Explorer
View class
Open →
26
Phosphodiesterase 4 Inhibitor
3 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$1.79B
→
Molecules3
Class share 0.6% of tracked Part D spend
Explorer
View class
Open →
27
BCL-2 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.51B
→
Molecules1
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
28
Proton Pump Inhibitor
10 molecules in class · 79 total generic manufacturers across the class
CY24 Part D spend$1.50B
→
Molecules10
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
29
CD20-directed Cytolytic Antibody
8 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.46B
→
Molecules8
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
30
Prostacyclin Receptor Agonist
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend$1.41B
→
Molecules1
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
31
Prostaglandin Analog
15 molecules in class · 40 total generic manufacturers across the class
CY24 Part D spend$1.29B
→
Molecules15
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
32
P2Y12 Platelet Inhibitor
5 molecules in class · 39 total generic manufacturers across the class
CY24 Part D spend$1.29B
→
Molecules5
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
33
Nonsteroidal Anti-inflammatory Drug
35 molecules in class · 184 total generic manufacturers across the class
CY24 Part D spend$1.27B
→
Molecules35
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
34
RANK Ligand Inhibitor
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.26B
→
Molecules5
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
36
Corticosteroid
68 molecules in class · 249 total generic manufacturers across the class
CY24 Part D spend$1.26B
→
Molecules68
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
37
Prostacycline Vasodilator
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1.24B
→
Molecules4
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
40
Soluble Guanylate Cyclase Stimulator
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$1.16B
→
Molecules2
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
42
Opioid Agonist
16 molecules in class · 112 total generic manufacturers across the class
CY24 Part D spend$1.11B
→
Molecules16
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
43
Beta-Adrenergic Blocker
3 molecules in class · 57 total generic manufacturers across the class
CY24 Part D spend$1.06B
→
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
45
Cytochrome P450 17A1 Inhibitor
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$1.02B
→
Molecules1
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
46
Antiarrhythmic
9 molecules in class · 86 total generic manufacturers across the class
CY24 Part D spend$1.00B
→
Molecules9
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
48
Estrogen
21 molecules in class · 54 total generic manufacturers across the class
CY24 Part D spend$973.4M
→
Molecules21
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
50
Interleukin-6 Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$911.4M
→
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
51
Anticonvulsant
3 molecules in class · 103 total generic manufacturers across the class
CY24 Part D spend$830.3M
→
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
53
Parathyroid Hormone Analog
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$757.1M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
55
Anti-epileptic Agent
14 molecules in class · 104 total generic manufacturers across the class
CY24 Part D spend$714.8M
→
Molecules14
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
58
Phosphate Binder
3 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$645.2M
→
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
59
Benzodiazepine
22 molecules in class · 94 total generic manufacturers across the class
CY24 Part D spend$638.0M
→
Molecules22
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
60
Biguanide (Antidiabetic)
1 molecule in class · 40 total generic manufacturers across the class
CY24 Part D spend$617.0M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
61
Angiotensin 2 Receptor Blocker
11 molecules in class · 104 total generic manufacturers across the class
CY24 Part D spend$561.9M
→
Molecules11
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
62
Progestin Antagonist
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$550.8M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
63
Mood Stabilizer
3 molecules in class · 42 total generic manufacturers across the class
CY24 Part D spend$550.4M
→
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
64
GLP-2 Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$549.0M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
67
Partial Opioid Agonist
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$536.9M
→
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
68
Cardiac Myosin Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$533.9M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
69
Interferon beta
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$528.5M
→
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
70
Anti-IgE
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$522.7M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
72
Aminosalicylate
3 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$511.7M
→
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
73
Interleukin-5 Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$511.2M
→
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
74
Serotonin Reuptake Inhibitor
4 molecules in class · 54 total generic manufacturers across the class
CY24 Part D spend$508.3M
→
Molecules4
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
75
Isocitrate Dehydrogenase 1 Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$503.9M
→
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
76
Azole Antifungal
20 molecules in class · 98 total generic manufacturers across the class
CY24 Part D spend$501.4M
→
Molecules20
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
77
ACE Inhibitor
5 molecules in class · 42 total generic manufacturers across the class
CY24 Part D spend$482.0M
→
Molecules5
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
79
alpha-Adrenergic Blocker
6 molecules in class · 49 total generic manufacturers across the class
CY24 Part D spend$479.2M
→
Molecules6
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
80
Potassium Supplement
1 molecule in class · 36 total generic manufacturers across the class
CY24 Part D spend$476.9M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
81
Calcium Channel Blocker
2 molecules in class · 43 total generic manufacturers across the class
CY24 Part D spend$467.4M
→
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
82
Alpha-1 Adrenergic Blocker
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$465.2M
→
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
83
Cholinergic Muscarinic Antagonist
5 molecules in class · 60 total generic manufacturers across the class
CY24 Part D spend$457.1M
→
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
84
Loop Diuretic
5 molecules in class · 53 total generic manufacturers across the class
CY24 Part D spend$448.1M
→
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
85
Estrogen Receptor Antagonist
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend$437.1M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
87
Complement Inhibitor
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$405.0M
→
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
88
Plasma Kallikrein Inhibitor
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$384.0M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
89
beta-Adrenergic Blocker
10 molecules in class · 87 total generic manufacturers across the class
CY24 Part D spend$376.5M
→
Molecules10
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
90
SGLT2 Inhibitor (Antidiabetic)
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$364.8M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
91
Purine Antimetabolite
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$364.2M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
92
Cholinesterase Inhibitor
5 molecules in class · 59 total generic manufacturers across the class
CY24 Part D spend$361.4M
→
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
93
Hypoxia-inducible Factor Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$356.6M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
94
Anticholinergic
12 molecules in class · 75 total generic manufacturers across the class
CY24 Part D spend$354.1M
→
Molecules12
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
95
Amide Local Anesthetic
24 molecules in class · 47 total generic manufacturers across the class
CY24 Part D spend$350.5M
→
Molecules24
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
98
Thymic Stromal Lymphopoietin Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$340.1M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
100
Integrin Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$338.9M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
101
Leukocyte Growth Factor
15 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$336.5M
→
Molecules15
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
103
Uric Acid-specific Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$322.8M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
105
Pyrimidine Synthesis Inhibitor
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$319.2M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
107
Central Nervous System Stimulant
12 molecules in class · 88 total generic manufacturers across the class
CY24 Part D spend$296.7M
→
Molecules12
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
108
Orexin Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$291.6M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
111
Ophthalmic Alpha-2 Agonist
1 molecule in class · 11 total generic manufacturers across the class
CY24 Part D spend$267.0M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
112
Histamine-2 Receptor Antagonist
6 molecules in class · 52 total generic manufacturers across the class
CY24 Part D spend$266.7M
→
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
113
Recombinant Human Growth Hormone
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$261.4M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
114
Pyridone
2 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$259.4M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
115
Serotonin Modulator (Antidepressant)
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$255.2M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
116
Tricyclic Antidepressant
7 molecules in class · 67 total generic manufacturers across the class
CY24 Part D spend$247.4M
→
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
117
Serotonin-3 Receptor Antagonist
6 molecules in class · 49 total generic manufacturers across the class
CY24 Part D spend$244.9M
→
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
118
Macrolide Antibacterial
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$241.3M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
121
Leukotriene Receptor Antagonist
2 molecules in class · 24 total generic manufacturers across the class
CY24 Part D spend$233.0M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
123
Phosphodiesterase 5 Inhibitor
4 molecules in class · 59 total generic manufacturers across the class
CY24 Part D spend$228.0M
→
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
124
Vasopressin V2 Receptor Antagonist
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$227.8M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
125
Nonergot Dopamine Agonist
3 molecules in class · 29 total generic manufacturers across the class
CY24 Part D spend$226.1M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
126
Skeletal Muscle Relaxant
3 molecules in class · 37 total generic manufacturers across the class
CY24 Part D spend$221.1M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
127
Nucleoside Metabolic Inhibitor
16 molecules in class · 97 total generic manufacturers across the class
CY24 Part D spend$215.1M
→
Molecules16
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
128
Histamine-1 Receptor Antagonist
10 molecules in class · 53 total generic manufacturers across the class
CY24 Part D spend$214.1M
→
Molecules10
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
129
Androgen
7 molecules in class · 28 total generic manufacturers across the class
CY24 Part D spend$210.9M
→
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
130
Nitrate Vasodilator
8 molecules in class · 31 total generic manufacturers across the class
CY24 Part D spend$205.9M
→
Molecules8
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
131
Sulfonylurea
8 molecules in class · 36 total generic manufacturers across the class
CY24 Part D spend$204.6M
→
Molecules8
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
133
Xanthine Oxidase Inhibitor
3 molecules in class · 26 total generic manufacturers across the class
CY24 Part D spend$200.9M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
134
5-alpha Reductase Inhibitor
4 molecules in class · 22 total generic manufacturers across the class
CY24 Part D spend$199.5M
→
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
135
HMG-CoA Reductase Inhibitor (Statin)
2 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$199.2M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
136
Hedgehog Pathway Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$196.4M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
137
Acetylcholine Release Inhibitor
6 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$195.3M
→
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
138
Influenza A M2 Protein Inhibitor
1 molecule in class · 19 total generic manufacturers across the class
CY24 Part D spend$190.5M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
139
Lipopeptide Antibacterial
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$188.0M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
140
Aluminum Complex
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend$186.8M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
141
Tetracycline-class Antibacterial
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$185.4M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
142
Adrenergic Agonist
6 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$182.9M
→
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
143
Cephalosporin Antibacterial
13 molecules in class · 51 total generic manufacturers across the class
CY24 Part D spend$182.3M
→
Molecules13
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
144
Melatonin Receptor Agonist
2 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend$180.8M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
145
Phenothiazine
9 molecules in class · 98 total generic manufacturers across the class
CY24 Part D spend$179.5M
→
Molecules9
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
149
Antihypoglycemic Agent
4 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$172.2M
→
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
150
Sucrose-specific Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$169.2M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
151
Bile Acid Sequestrant
7 molecules in class · 26 total generic manufacturers across the class
CY24 Part D spend$168.2M
→
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
152
Carbonic Anhydrase Inhibitor
7 molecules in class · 39 total generic manufacturers across the class
CY24 Part D spend$167.6M
→
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
154
Aldosterone Antagonist
3 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$164.5M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
155
Opioid Analgesic
2 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend$163.2M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
156
Anti-anginal
1 molecule in class · 20 total generic manufacturers across the class
CY24 Part D spend$162.9M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
157
Bisphosphonate
3 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$159.0M
→
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
158
Bile Acid
4 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$156.9M
→
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
159
DMARD (Antimalarial)
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$156.6M
→
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
160
Non-Benzodiazepine Hypnotic (Z-Drug)
2 molecules in class · 22 total generic manufacturers across the class
CY24 Part D spend$155.9M
→
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
161
Retinoid
19 molecules in class · 52 total generic manufacturers across the class
CY24 Part D spend$154.6M
→
Molecules19
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
162
alpha-Adrenergic Agonist
5 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$153.5M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
163
Complement 5a Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$149.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
164
Nuclear Export Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$147.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
165
Tetracycline-class Drug
3 molecules in class · 60 total generic manufacturers across the class
CY24 Part D spend$147.0M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
166
Iron Chelator
4 molecules in class · 24 total generic manufacturers across the class
CY24 Part D spend$143.8M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
167
Central alpha-2 Adrenergic Agonist
5 molecules in class · 65 total generic manufacturers across the class
CY24 Part D spend$138.5M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
169
Arteriolar Vasodilator
2 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$134.6M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
171
Penem Antibacterial
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$134.3M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
172
gamma-Aminobutyric Acid-ergic Agonist
2 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$134.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
173
Aromatase Inhibitor
5 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$132.6M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
174
Potassium Channel Blocker
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$126.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
175
Alkaloid
3 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$124.2M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
176
Interleukin-13 Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$123.6M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
177
Thiazide Diuretic
30 molecules in class · 103 total generic manufacturers across the class
CY24 Part D spend$122.0M
→
Molecules30
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
178
Calcium-sensing Receptor Agonist
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$120.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
179
Low Molecular Weight Heparin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$118.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
181
Bradykinin B2 Receptor Antagonist
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$116.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
182
Osmotic Laxative
13 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$116.6M
→
Molecules13
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
183
Polyene Antifungal
6 molecules in class · 37 total generic manufacturers across the class
CY24 Part D spend$116.2M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
184
Tyrosine Kinase 2 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$115.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
186
Muscle Relaxant
6 molecules in class · 55 total generic manufacturers across the class
CY24 Part D spend$114.3M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
187
Fluoroquinolone Antibacterial
6 molecules in class · 61 total generic manufacturers across the class
CY24 Part D spend$113.2M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
190
Serotonin-4 Receptor Agonist
1 molecule in class · 16 total generic manufacturers across the class
CY24 Part D spend$103.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
191
Immunosuppressant
1 molecule in class · 24 total generic manufacturers across the class
CY24 Part D spend$101.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
192
Thiazide-like Diuretic
6 molecules in class · 35 total generic manufacturers across the class
CY24 Part D spend$99.9M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
194
Folate Analog Metabolic Inhibitor
5 molecules in class · 28 total generic manufacturers across the class
CY24 Part D spend$93.3M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
195
Protease Inhibitor
3 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$90.0M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
196
Chloride Channel Activator
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$89.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
197
Opioid Antagonist
3 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend$89.7M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
198
Nitroimidazole Antimicrobial
9 molecules in class · 29 total generic manufacturers across the class
CY24 Part D spend$88.0M
→
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
199
mu-Opioid Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$87.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
201
Cephalosporin (Antibiotic)
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$81.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
202
Estrogen Agonist/Antagonist
4 molecules in class · 19 total generic manufacturers across the class
CY24 Part D spend$77.6M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
203
Glucosylceramide Synthase Inhibitor
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$77.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
206
Glycopeptide Antibacterial
1 molecule in class · 21 total generic manufacturers across the class
CY24 Part D spend$75.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
207
Macrolide (Antibiotic)
1 molecule in class · 20 total generic manufacturers across the class
CY24 Part D spend$72.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
208
Antisense Oligonucleotide
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$71.6M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
209
Neurokinin 3 Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$70.1M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
210
Monoamine Oxidase Inhibitor
2 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$69.9M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
211
Antirheumatic Agent
2 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$69.9M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
212
Vitamin K Antagonist (Anticoagulant)
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$68.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
215
Alkylating Drug
16 molecules in class · 77 total generic manufacturers across the class
CY24 Part D spend$64.9M
→
Molecules16
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
216
Lincosamide (Antibiotic)
1 molecule in class · 26 total generic manufacturers across the class
CY24 Part D spend$64.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
218
Cholinergic Receptor Agonist
2 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$63.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
220
Antimalarial
6 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$61.4M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
221
Progestin
10 molecules in class · 58 total generic manufacturers across the class
CY24 Part D spend$60.0M
→
Molecules10
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
223
Cortisol Synthesis Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$59.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
224
Sympathomimetic-like Agent
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$58.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
227
Cardiac Glycoside
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$55.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
229
Aminoglycoside Antibacterial
8 molecules in class · 41 total generic manufacturers across the class
CY24 Part D spend$53.3M
→
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
230
Interleukin-1 Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$53.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
233
Norepinephrine Reuptake Inhibitor
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$50.5M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
234
Quinolone Antimicrobial
9 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$50.3M
→
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
235
Programmed Death Ligand-1 Blocker
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$49.7M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
236
beta2-Adrenergic Agonist
5 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend$48.7M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
237
Reducing and Complexing Thiol
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$47.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
238
HER2/neu Receptor Antagonist
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$46.3M
→
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
239
Interferon alpha
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$46.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
240
Aminopenicillin (Antibiotic)
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$45.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
241
5-Lipoxygenase Inhibitor
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$45.5M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
242
Aromatic Amino Acid
3 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend$44.9M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
243
Typical Antipsychotic
3 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend$44.8M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
244
Thyroid Hormone
2 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$43.1M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
245
Aryl Hydrocarbon Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$43.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
246
Vitamin D3 Analog
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$41.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
248
Antiemetic
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$38.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
249
Phenylalanine Metabolizing Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$38.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
250
Ergotamine Derivative
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$38.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
252
Vitamin D Analog
3 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$35.6M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
253
Proteasome Inhibitor
2 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$35.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
254
Oxaborole Antifungal
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$34.1M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
256
Phenylalanine Hydroxylase Activator
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$32.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
258
CCR5 Co-receptor Antagonist
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$32.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
259
Glinide
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$29.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
260
CD38-directed Cytolytic Antibody
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$29.3M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
261
Leptin Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$28.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
262
mTOR Inhibitor Immunosuppressant
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$27.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
263
Thrombopoietin Receptor Agonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$27.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
264
Lipoglycopeptide Antibacterial
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$27.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
265
Oxazolidinone Antibacterial
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend$26.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
266
Phosphodiesterase 3 Inhibitor
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$26.4M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
268
Somatostatin Analog
2 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend$24.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
269
DPP-4 Inhibitor (Antidiabetic)
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$24.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
270
Vasopressin Analog
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$24.1M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
271
Ergot Derivative
3 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$23.1M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
273
Antimetabolite
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$21.1M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
274
Penicillin-class Antibacterial
7 molecules in class · 27 total generic manufacturers across the class
CY24 Part D spend$20.6M
→
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
275
Provitamin D2 Compound
5 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$20.2M
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
276
Dopamine-2 Receptor Antagonist
3 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend$20.1M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
277
Antiparasitic
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$19.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
278
Anthelmintic
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$19.7M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
279
Thyroid Hormone Synthesis Inhibitor
2 molecules in class · 11 total generic manufacturers across the class
CY24 Part D spend$19.1M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
280
Blood Viscosity Reducer
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$19.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
281
Benzothiazole
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$19.0M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
283
CTLA-4-directed Blocking Antibody
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$18.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
285
Nicotinic Acid
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$18.1M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
286
Sulfonamide Antibacterial
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$16.6M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
287
Cholinergic Muscarinic Agonist
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$15.9M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
289
Allylamine Antifungal
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend$15.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
290
Mast Cell Stabilizer
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$15.2M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
291
Pyrethroid
2 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend$14.0M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
292
Echinocandin Antifungal
4 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$13.5M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
293
Interleukin-17 Receptor A Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$13.1M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
294
Histone Deacetylase Inhibitor
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$13.1M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
296
Cholinergic Nicotinic Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$12.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
297
Interleukin-36 Receptor Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$12.1M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
298
Antidiarrheal
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$11.8M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
300
Sulfone
4 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$11.5M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
301
Nucleoside Analog Antifungal
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$11.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
302
Rifamycin Antimycobacterial
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$11.2M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
303
Pyruvate Kinase Activator
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$10.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
304
alpha-Glucosidase Inhibitor
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$10.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
306
Vitamin C
53 molecules in class · 11 total generic manufacturers across the class
CY24 Part D spend$10.2M
→
Molecules53
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
307
Cannabinoid
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$10.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
308
Amino Acid
14 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$10.0M
→
Molecules14
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
309
Cytochrome P450 3A Inhibitor
8 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$9.8M
→
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
310
Nitrofuran Antibacterial
9 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$9.8M
→
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
311
Potassium-sparing Diuretic
3 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$9.6M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
312
Copper Chelator
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$8.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
313
Microtubule Inhibitor
6 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$8.3M
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
316
Macrolide Antimicrobial
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$7.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
317
Tetracycline-class Antimicrobial
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$7.9M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
318
Antifibrinolytic Agent
2 molecules in class · 38 total generic manufacturers across the class
CY24 Part D spend$7.8M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
322
Folate Analog
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$7.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
323
Platelet-reducing Agent
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$7.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
324
Catecholamine Synthesis Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$6.6M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
325
CD30-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$6.5M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
326
Carnitine Analog
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$6.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
327
Antiprotozoal
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$6.2M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
329
Sodium Channel Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.7M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
330
Histamine-1 Receptor Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$5.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
331
Vitamin D2 Analog
2 molecules in class · 19 total generic manufacturers across the class
CY24 Part D spend$5.4M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
332
Macrolide
4 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$5.3M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
333
Prostaglandin E1 Analog
3 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$5.3M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
334
Potassium Binder
2 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend$4.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
335
Medium-chain Triglyceride
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$4.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
337
Monobactam Antibacterial
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend$3.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
339
Lipid-based Polyene Antifungal
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$3.7M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
340
Opioid Agonist/Antagonist
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$3.5M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
342
Aldehyde Dehydrogenase Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$3.5M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
343
Non-narcotic Antitussive
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$3.4M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
345
Methylating Agent
3 molecules in class · 2 total generic manufacturers across the class
CY24 Part D spend$3.2M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
348
Antidote
3 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$3.0M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
349
Nucleoside Analog Antiviral
3 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$2.8M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
350
Antileishmanial
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$2.8M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
351
Adrenal Steroid Synthesis Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$2.1M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
352
Platinum-based Drug
3 molecules in class · 31 total generic manufacturers across the class
CY24 Part D spend$1.8M
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
353
Platelet Aggregation Inhibitor
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$1.8M
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
355
Antimycobacterial
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1.8M
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
356
Interferon gamma Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
357
Polyene Antimicrobial
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
358
Complement Factor D Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
360
Urease Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$975426
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
361
Pediculicide
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$930240
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
362
Amyloid Beta-directed Antibody
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$856927
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
363
Photoactivated Radical Generator
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend$785078
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
364
Topoisomerase Inhibitor
3 molecules in class · 27 total generic manufacturers across the class
CY24 Part D spend$780820
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
366
Lincosamide Antibacterial
4 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$730703
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
367
Intestinal Lipase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$595414
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
368
Hematopoietic Stem Cell Mobilizer
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$534430
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
370
Thyroid Stimulating Hormone
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$467014
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
371
Analgesic/Antipyretic
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$179365
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
372
Lead Chelator
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$165312
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
373
Osmotic Diuretic
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$125842
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
374
Benzodiazepine Antagonist
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend$76946
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
377
alpha-1 Adrenergic Agonist
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$56521
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
378
Local Anesthetic
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$48308
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
379
Polymyxin-class Antibacterial
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$29910
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
380
Neuraminidase Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$24175
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
382
Sympathomimetic Amine Anorectic
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$17447
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
383
Progesterone
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$11832
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
384
Cytoprotective Agent
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1356
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
385
Antiseptic
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1323
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
386
Sympathomimetic Pressor
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$251
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
387
Radioactive Diagnostic Agent
27 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules27
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
388
Radiographic Contrast Agent
17 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules17
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
389
Vitamin D
12 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules12
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
390
Calculi Dissolution Agent
11 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules11
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
391
General Anesthetic
10 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules10
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
393
Barbiturate
8 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
394
Endoglycosidase
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
395
Vitamin B12
6 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
396
Lipid Emulsion
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
397
Parenteral Iron Replacement
5 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
399
Tubulin Inhibiting Agent
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
400
Human Immunoglobulin G
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
402
Standardized Chemical Allergen
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
403
Vasodilator
4 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
404
Adenosine Receptor Agonist
3 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
405
Adrenocorticotropic Hormone
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
406
Anti-coagulant
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
407
Asparagine-specific Enzyme
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
409
Neonatal Fc Receptor Blocker
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
410
Plasma Volume Expander
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
412
Sulfonamide Antimicrobial
3 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
413
Surfactant
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
414
beta Lactamase Inhibitor
3 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
416
Antimetabolite Immunosuppressant
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
419
Gonadotropin
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
420
Hepatitis C Virus NS5A Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
421
Inhalation Diagnostic Agent
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
422
Melanin Synthesis Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
423
Paramagnetic Contrast Agent
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
424
Skin Test Antigen
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
425
Topical Corticosteroid
2 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
426
Vitamin K
2 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
427
l-Thyroxine
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
428
APOC-III-directed RNA Interaction
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
429
Actinomycin
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
430
Angiopoietin-like 3 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
431
Antihistamine
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
432
Antimigraine Agent
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
434
Bispecific HER2-directed Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
436
CD123 Interaction
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
437
CD19-directed Cytolytic Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
438
CD22-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
439
CD25-directed Cytotoxin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
440
CD3-directed Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
441
CD33-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
442
CD4-directed Blocking Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
443
CD52-directed Cytolytic Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
444
CNS Stimulant (Amphetamine)
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
445
CXC Chemokine Receptor 4 Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
446
Calcitonin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
447
Calcium
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
448
Carboxypeptidase
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
449
Catecholamine
1 molecule in class · 17 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
450
Cholecystokinin Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
453
Complement C5 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
455
Cough/Cold Combination
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
456
Cytolytic Agent
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
457
Decorporation Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
458
Depolarizing Neuromuscular Blocker
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
459
Diagnostic Dye
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
460
Disclosing Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
461
Ectoparasiticide
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
462
Erythroid Maturation Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
463
Erythropoiesis-stimulating Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
464
Expectorant
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
465
Farnesyltransferase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
466
Gadolinium-based Contrast Agent
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
467
Gamma Secretase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
469
Helicobacter pylori Diagnostic
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
471
Human Blood Coagulation Factor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
472
Human Immunoglobulin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
475
Hyperpolarized Contrast Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
476
Immunoglobulin G
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
477
Inhaled Corticosteroid
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
478
Insulin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
480
Interferon alfa-2b
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
481
Interferon gamma
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
483
Interleukin-6 Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
485
Lymphocyte Growth Factor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
486
Lysosomal beta Glucuronidase
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
487
Melanocortin 4 Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
488
Menin Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
489
Methylxanthine
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
491
Nitrogen Binding Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
492
Ophthalmic Combination
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
494
Oxidation-Reduction Agent
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
495
Oxytocic
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
496
Parathyroid Hormone
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
497
Partial Opioid Agonist/Antagonist
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
499
Photoenhancer
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
500
Prostacycline
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
501
Renal Dehydropeptidase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
502
Sclerosing Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
503
Selectin Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
504
Semifluorinated Alkane
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
508
Unfractionated Heparin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
509
Vasoconstrictor
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
510
Vasopressin Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
512
alpha-Hydroxy Acid
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
513
beta-Adrenergic Agonist
1 molecule in class · 11 total generic manufacturers across the class
CY24 Part D spend—
→
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →